Expression and function role of DNA methyltransferase 1 in human bladder cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer

• Publication date

  2011-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cncr.26150PMID 21523767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.

  2010cited by this paper
• Updated results of bladder-sparing trimodality approach for invasive bladder cancer.

  2010cited by this paper
• Drugs that Target Specificity Proteins Downregulate Epidermal Growth Factor Receptor in Bladder Cancer Cells

  2010cited by this paper
• The PI3K pathway as drug target in human cancer.

  2010cited by this paper
• Role of DNA methyltransferase 1 in hormone-resistant prostate cancer

  2010cited by this paper
• Uni and Epig

  2010cited by this paper
• Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue.

  2010cited by this paper
• Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response

  2009cited by this paper
• Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.

  2009cited by this paper
• Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with vandetanib sensitizes bladder cancer cells to cisplatin in a dose‐ and sequence‐dependent manner

  2009cited by this paper
• The predictive role of E2-EPF ubiquitin carrier protein in esophageal squamous cell carcinoma

  2009cited by this paper
• Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma.

  2009cited by this paper
• Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

  2009cited by this paper
• Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer

  2009cited by this paper
• The promises and pitfalls of epigenetic therapies in solid tumours.

  2009cited by this paper
• Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.

  2009cited by this paper
• Growth factors and receptors as prognostic markers in urothelial carcinoma

  2008cited by this paper
• Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer.

  2008cited by this paper
• Alterations of DNA methylation and clinicopathological diversity of human cancers

  2008cited by this paper
• Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin.

  2008cited by this paper
• DNMT1 as a Molecular Target in a Multimodality-Resistant Phenotype in Tumor Cells

  2008cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue

  2006cited by this paper
• Trimodality treatment and selective organ preservation for bladder cancer.

  2006cited by this paper
• Epigenetic therapy of cancer: past, present and future

  2006cited by this paper
• Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.

  2005cited by this paper
• The role of apoptosis in cancer development and treatment response

  2005cited by this paper
• DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.

  2005cited by this paper
• Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach.

  2004cited by this paper
• Detection of Methylated Apoptosis-Associated Genes in Urine Sediments of Bladder Cancer Patients

  2004cited by this paper
• Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy.

  2004cited by this paper
• Phosphorylation of histone H2AX as a measure of radiosensitivity.

  2004cited by this paper
• Pathways of apoptotic and non-apoptotic death in tumour cells

  2004cited by this paper
• The history of cancer epigenetics

  2004cited by this paper
• Biochemistry and biology of mammalian DNA methyltransferases

  2004influential reference
• Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder.

  2003cited by this paper
• DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells

  2003cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• DNA methylation and chromatin – unraveling the tangled web

  2002cited by this paper
• Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.

  2000cited by this paper
• Bladder cancer

  2000cited by this paper
• The DNA methyltransferases of mammals.

  2000influential reference
• Progressive increases in de novo methylation of CpG islands in bladder cancer.

  2000cited by this paper
• Bladder cancer.

  1998cited by this paper
• Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.

  1994cited by this paper
• T3 receptor suppression of Sp1-dependent transcription from the epidermal growth factor receptor promoter via overlapping DNA-binding sites.

  1993cited by this paper
• Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix

  1992cited by this paper
• An immunohistologic evaluation of C‐erbB‐2 gene product in patients with urinary bladder carcinoma

  1992cited by this paper
• Expression of c-erbB-2 gene product in urinary bladder cancer.

  1991cited by this paper

• A review on recent advances in assays for DNMT1: a promising diagnostic biomarker for multiple human cancers.

  2024cites this paper
• Exploring the mechanism of curcumin in the treatment of colon cancer based on network pharmacology and molecular docking

  2023cites this paper
• miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression

  2022cites this paper
• High DNMT1 Expression in Stromal Fibroblasts Promotes Angiogenesis and Unfavorable Outcome in Locally Advanced Breast Cancer Patients

  2022cites this paper
• Coexpression Network Analysis of lncRNA Associated with Overexpression of DNMT1 in Esophageal Epithelial Cells

  2021cites this paper
• Novel serum peptide model revealed by MALDI-TOF-MS and its diagnostic value in early bladder cancer

  2020influential citation
• Dysregulation of Redox Status in Urinary Bladder Cancer Patients

  2020cites this paper
• DNA Methylation as a Therapeutic Target for Bladder Cancer

  2020cites this paper
• Urothelial Cancer Stem Cell Heterogeneity.

  2019cites this paper
• Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis

  2019cites this paper
• Co-expression Network analysis of LncRNA associated with overexpression of DNMT1 in esophageal epithelial cells

  2019cites this paper
• Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria.

  2019cites this paper
• Antagonistic activities of miR-148a and DNMT1: Ectopic expression of miR-148a impairs DNMT1 mRNA and dwindle cell proliferation and survival.

  2018cites this paper
• Novel protein signatures suggest progression to muscular invasiveness in bladder cancer

  2018cites this paper
• NUSAP1 gene silencing inhibits cell proliferation, migration and invasion through inhibiting DNMT1 gene expression in human colorectal cancer

  2018cites this paper
• Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer

  2017cites this paper
• The prognostic role of epigenetic dysregulation in bladder cancer: A systematic review.

  2017cites this paper
• Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer

  2017cites this paper
• Expression of DNA methylation-related proteins in metastatic breast cancer.

  2017cites this paper
• Expression of DNA methylation-related proteins in invasive lobular carcinoma of breast: comparison to invasive ductal carcinoma.

  2017cites this paper
• Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs

  2017cites this paper
• Expression of DNA methylation-related proteins in breast phyllodes tumor

  2017cites this paper
• Title : The Prognostic Role of Epigenetic dysregulation in Bladder Cancer : A Systematic Review

  2017cites this paper
• Polymorphisms of the DNA Methyltransferase 1 Gene Predict Survival of Gastric Cancer Patients Receiving Tumorectomy

  2016cites this paper
• RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation

  2016influential citation
• Differential expression of the epigenetic methylation-related protein DNMT1 by breast cancer molecular subtype and stromal histology

  2016cites this paper
• Regulation of Chromatin Modifier Genes by Microrna Vis-À-Vis Regulation of Microrna by DNA Methylation and Histone Modifications in Human Cancer

  2016cites this paper
• Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis 1

  2016cites this paper
• Physiological and pathological implications of 5-hydroxymethylcytosine in diseases

  2016cites this paper
• DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis1

  2016cites this paper
• Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients

  2016cites this paper
• miR‐148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1

  2016influential citation
• Key signaling pathways in the muscle‐invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment

  2016cites this paper
• DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer

  2015cites this paper
• Overexpression of DNA methyltransferase 1 (DNMT1) protein in astrocytic tumour and its correlation with O6-methylguanine-DNA methyltransferase (MGMT) expression.

  2015cites this paper
• Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?

  2015cites this paper
• Causes of genome instability: the effect of low dose chemical exposures in modern society.

  2015cites this paper
• Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.

  2014cites this paper
• SOCS1 hypermethylation mediated by DNMT1 is associated with lipopolysaccharide-induced inflammatory cytokines in macrophages.

  2014cites this paper
• Thrombomodulin expression regulates tumorigenesis in bladder cancer

  2014cites this paper
• Regulatory variation: an emerging vantage point for cancer biology

  2014cites this paper
• Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma.

  2014cites this paper
• Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression.

  2014cites this paper
• IL-6 Expression Regulates Tumorigenicity and Correlates with Prognosis in Bladder Cancer

  2013cites this paper
• The E2F1/DNMT1 axis is associated with the development of AR negative castration resistant prostate cancer

  2013cites this paper
• Modulation of DNMT3A Expression and Nuclear Localization in Bladder Smooth Muscle Cells in Response to Obstructive Stimuli

  2012cites this paper
• The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma

  2012cites this paper